Scinovex
review Open AccessTop 1% cited

Hidden Killers: Human Fungal Infections

Science Translational Medicine · 2012 · Vol. 4(165) · pp. 165rv13–165rv13
Gordon D. BrownDavid W. DenningNeil A. R. GowStuart M. LevitzMihai G. NeteaTheodore C. White

Abstract

Although fungal infections contribute substantially to human morbidity and mortality, the impact of these diseases on human health is not widely appreciated. Moreover, despite the urgent need for efficient diagnostic tests and safe and effective new drugs and vaccines, research into the pathophysiology of human fungal infections lags behind that of diseases caused by other pathogens. In this Review, we highlight the importance of fungi as human pathogens and discuss the challenges we face in combating the devastating invasive infections caused by these microorganisms, in particular in immunocompromised individuals.

Antifungal resistance and susceptibilityFungal Infections and StudiesInfectious Diseases and MycologyHuman healthIntensive care medicineMedicineHuman pathogenImmunologyBiologyEnvironmental health

MeSH terms

HumansMycoses

Funding

  • Medical Research Council
Citations
4,243
FWCI
54.24
field-weighted impact
References
79
Percentile
100%
vs. same field & year
Citations per year
Cited by
Assessment of anti-candidial activity of different homoeopathic medicines against Candida albicans
International Journal of Homoeopathic Sciences · 2019 · 1 citations
Global incidence and mortality of severe fungal disease
The Lancet Infectious Diseases · 2024 · 1,139 citations
The global problem of antifungal resistance: prevalence, mechanisms, and management
The Lancet Infectious Diseases · 2017 · 1,008 citations
The recent progress of isoxazole in medicinal chemistry
Bioorganic & Medicinal Chemistry · 2018 · 390 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.